Potential for Protection and Repair Following Injury to the Developing Brain: A Role for Erythropoietin?

Pediatric Research

Volumn 57, Issue 5, 2005, Pages 110R-117R

  Sola, Augusto ^a   Wen, TONG CHUN ^a   Hamrick, Shannon E G ^a   Ferriero, Donna M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTIHISTAMINIC AGENT; ANTIOXIDANT; ERYTHROPOIETIN; FRUCTOSE BISPHOSPHATE; INTERLEUKIN 10; INTERLEUKIN 1BETA; MAGNESIUM; MAGNESIUM SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N(G) NITROARGININE;

BLOOD CLOTTING DISORDER; BRAIN DEVELOPMENT; BRAIN INJURY; BRAIN PROTECTION; CELL REGENERATION; CLINICAL TRIAL; DIARRHEA; DRUG DISTRIBUTION; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; EDEMA; ERYTHROCYTE APLASIA; ERYTHROCYTOSIS; EVIDENCE BASED MEDICINE; FEVER; GENE THERAPY; HUMAN; HYPERTENSION; HYPOTHERMIA; NECROTIZING ENTEROCOLITIS; NERVE CELL LESION; NEUROPROTECTION; NEWBORN CARE; NONHUMAN; PERINATAL MORBIDITY; PERINATAL MORTALITY; PERINATAL PERIOD; POLYCYTHEMIA; PREMATURITY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SOCIOECONOMICS; SYSTEMATIC REVIEW; THROMBOEMBOLISM; TREATMENT INDICATION; VOMITING;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BRAIN; BRAIN INJURIES; BRAIN ISCHEMIA; ERYTHROPOIETIN; FREE RADICALS; HUMANS; MODELS, BIOLOGICAL; NEURONS; OXIDANTS; RECEPTORS, ERYTHROPOIETIN; WOUND HEALING;

EID: 17844388368     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/01.PDR.0000159571.50758.39     Document Type: Review

References (105)

1. Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR 2000 Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. N Engl J Med 343:378-384
2. Vannucci RC 2000 Hypoxic-ischemic encephalopathy. Am J Perinatol 17:113-120
3. Edwards AD, Azzopardi DV 2000 Perinatal hypoxia-ischemia and brain injury. Pediatr Res 47:431-432
4. Lynch JK, Hirtz DG, DeVeber G, Nelson KB 2002 Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics 109:116-123
5. Lynch JK, Nelson KB 2001 Epidemiology of perinatal stroke. Curr Opin Pediatr 13:499-505
6. Stillger A, Kumar RK 1999 Neonatal cerebral infarction: USS or CT for imaging? Indian J Pediatr 66:141-143
7. Nelson KB, Lynch JK 2004 Stroke in newborn infants. Lancet Neurol 3:153-158
8. Ramaswamy V, Miller SP, Barkovich AJ, Partridge JC, Ferriero DM 2004 Perinatal stroke in term infants with neonatal encephalopathy. Neurology 62:2088-2091
9. Volpe JJ 2001 Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 50:553-562
10. Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ, Verter J, Temprosa M, Wright LL, Ehrenkranz RA, Fanaroff AA, Stark A, Carlow W, Tyson JE, Donovan FF, Shankaran S, Stevenson DK 2001 Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 107:El
11. Ferriero DM 2004 Neonatal brain injury. N Engl J Med 351:1985-1995
12. Volpe JJ 2001 Perinatal brain injury: from pathogenesis to neuroprotection. Ment Retard Dev Disabil Res Rev 7:56-64
13. Jensen A, Garnier Y, Middelanis J, Berger R 2003 Perinatal brain damage-from pathophysiology to prevention. Eur J Obstet Gynecol Reprod Biol 110(suppl 1):S70-S79
14. Hamrick SE, Ferriero DM 2003 The injury response in the term newborn brain: can we neuroprotect? Curr Opin Neurol 16:147-154
15. McQuillen PS, Ferriero DM 2004 Selective vulnerability in the developing central nervous system. Pediatr Neurol 30:227-235
16. Aboul-Enein F, Rauschka H, Kornek B, Stadelmann C, Stefferl A, Bruck W, Lucchinetti C, Schmidbauer M, Jellinger K, Lassmann H 2003 Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J Neuorpathol Exp Neurol 62:25-33
17. Walton M, Connor B, Lawlor B, Young D, Sirimanne E, Gluckman P Cole G, Dragunow M 1999 Neuronal death and survival in two models of hypoxic-ischemic brain damage. Brain Res Brain Res Rev 29:137-168
18. Aito H, Aalto KT, Raivio KO 2002 Biphasic ATP depletion caused by transient oxidative exposure is associated with apoptotic cell death in rat embryonal cortical neurons. Pediatr Res 52:40-45
19. Grether JK, Nelson KB 1997 Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 278:207-211
20. Marret S, Gressens P, Evrard P 1996 Neuronal migration disorders induced by ibotenate in the neocortex. Proc Natl Acad Sci U S A 17:543-551
21. Marret S, Mukendi R, Gadisseux JF, Gressens P, Evrard P 1995 Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic like lesions. J Neuropathol Exp Neurol 54:358-370
22. Gressens P, Marret S, Evrard P 1996 Developmental spectrum of the excitotoxic cascade induced by ibotenate: a model of hypoxic insults in fetuses and neonates. Neuropathol Appl Neurobiol 22:498-502
23. Tahraoui SL, Marret S, Bodénant C, Leroux P, Dommergues MA, Evrard P, Gressens P 2001 Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter. Brain Pathol 11:56-71
24. Dommergues MA, Plaisant F, Verney C, Gressens P 2003 Early microglial activation following neonatal excitotoxic brain damage in mice: a target for neuroprotection. Neuroscience 121:619-628
25. Follett PL, Rosenberg PA, Volpe JJ, Jensen FE 2000 NBQX attenuates excitotoxic injury in developing white matter. J Neurosci 20:9235-9241
26. Xu H, Barks JD, Liu YQ, Silverstein FS 2001 AMPA-induced suppression of oligodendroglial gene expression in neonatal rat brain. Brain Res Dev Brain Res 132:175-180
27. Nelson KB, Grether JK, Dambrosia JM, Walsh E, Kohler S, Satyanarayana G, Nelson PG, Dickens BF, Phillips TM 2003 Neonatal cytokines and cerebral palsy in very preterm infants. Pediatr Res 53:600-607
28. Dommergues MA, Patkai J, Renauld JC, Evrard P, Gressens P 2000 Pro-inflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol 47:54-63
29. Plaisant F, Dommergues MA, Campbell IL, Gressens P 2002 Effects of systemic and CNS pro-inflammatory cytokines on NMDA and AMPA receptors-mediated brain lesions in newborn mice. Pediatr Res 51:442A
30. Gressens P, Rogido M, Paindaveine B, Sola A 2002 The impact of neonatal intensive care practices on the developing brain. J Pediatr 140:646-653
31. Mesplès B, Plaisant F, Gressens P 2003 Effects of interleukin-10 on neonatal excitotoxic brain lesions in mice. Brain Res Dev Brain Res 141:25-32
32. Patkai J, Mesplès B, Dommergues MA, Fromont G, Thornton EM, Renauld JC, Evrard P Gressens P 2001 Deleterious effects of IL-9-activated mast cells and neuroprotection by antihistamine drugs in the developing mouse brain. Pediatr Res 50:222-230
33. Mesplès B, Fontaine RH, Lelièvre V, Launay JM, Gressens P 2005 Neuronal TGF-β1 mediates IL-9/mast cell interaction and exacerbate excitotoxicity in newborn mice. Neurobiol Dis 18:193-205
34. Palmer C, Towfighi J, Roberts RL, Heitjan DF 1993 Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats. Pediatr Res 33:405-411
35. Van Bel F, Shadid M, Moison RM, Dorrepaal CA, Fontijn J, Monteiro L, Van De Bor M, Berger HM 1998 Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity. Pediatrics 101:185-193
36. Hamada Y, Hayakawa T, Hattori H, Mikawa H 1994 Inhibitor of nitric oxide synthesis reduces hypoxic-ischemic brain damage in the neonatal rat. Pediatr Res 35:10-14
37. Ferriero DM, Holtzman DM, Black SM, Sheldon RA 1996 Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury. Neurobiol Dis 3:64-71
38. Nelson KB, Grether JK 1995 Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 95:263-269
39. Schendel DE, Berg CJ, Yeargin-Allsopp M, Boyle CA, Decoufle P 1996 Prenatal magnesium sulfate exposure and risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years. JAMA 276:1805-1810
40. Levene M, Blennow M, Whitelaw A, Hanko E, Fellman V, Hartley R 1995 Acute effects of two different doses of magnesium sulphate in infants with birth asphyxia. Arch Dis Child Fetal Neonatal Ed 73:F174-F177
41. Ichiba H, Tamai H, Negishi H, Ueda T, Kim TJ, Sumida Y, Takahashi Y, Fujinaga H, Minami H, Kansai Magnesium Study Group 2002 Randomized controlled trial of magnesium sulfate infusion for severe birth asphyxia. Pediatr Int 44:505-509
42. Garnier Y, Middelanis J, Jensen A, Berger R 2002 Neuroprotective effects of magnesium on metabolic disturbances in fetal hippocampal slices after oxygen-glucose deprivation: mediation by nitric oxide system. J Soc Gynecol Investig 9:86-92
43. Sola A, Berrios M, Sheldon RA, Ferriero DM, Gregory GA 1996 Fructose-1,6-bisphosphate after hypoxic ischemic injury is protective to the neonatal rat brain. Brain Res 741:294-299
44. Rogido M, Husson I, Bonnier C, Lallemand MC, Merienne C, Gregory GA, Sola A, Gressens P 2003 Fructose-1, 6 bisphosphate prevents excitotoxic neuronal cell death in the neonatal mouse brain. Brain Res Dev Brain Res 140:287-297
45. Gunn AJ, Gluckman PD, Gunn TR 1998 Selective head cooling in newborn infants after perinatal asphyxia: a safety study. Pediatrics 102:885-892
46. Azzopardi D, Robertson NJ, Cowan FM, Rutherford MA, Rampling M, Edwards AD 2000 Pilot study of treatment with whole body hypothermia for neonatal encephalopathy. Pediatrics 106:684-694
47. Battin MR, Penrice J, Gunn TR, Gunn AJ 2003 Treatment of term infants with head cooling and mild systemic hypothermia (35.0 degrees C and 34.5 degrees C) after perinatal asphyxia. Pediatrics 111:244-251
48. Gluckman PD, Wyatt JS, Azzopardi RB, Ballard R, Edwards D, Ferriero DM, Polin RA, Robertson C, Thoresen M, Whitelaw A, Gunn AJ, the CoolCap Study 2004 Selective head cooling with mild systemic hypothermia to improve neurodevelopmental outcome following neonatal encephalopathy. Pediatr Res 55:582A
49. Shankaran S, Laptook AR, Ehrenkranz RA, Donovan EA, Fanaroff AA, Tyson JE, McDonald SA, Poole K, Wright LL, Goldberg R, NICHD, Neonatal Research Network 2004 Safety of whole body hypothermia for hypoxic-ischemic encephalopathy (HIE). Pediatr Res 55:582A
50. Sheldon RA, Jiang X, Francisco C, Christen S, Vexler ZS, Täuber MG, Ferriero DM 2004 Manipulation of antioxidant pathways in neonatal murine brain. Pediatr Res 56:656-662
51. Fisher JW 2003 Erythropoietin: physiology and pharmacology update. Exp Biol Med 228:1-14
52. Liu C, Shen K, Liu Z, Noguchi CT 1997 Regulated human erythropoietin receptor expression in mouse brain. J Biol Chem 272:32395-32400
53. Juul SE, Anderson DK, Li Y, Christensen RD 1998 Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr Res 43:40-49
54. Wu H, Lee SH, Gao J, Liu X, Iruela-Arispe ML1999 Inactivation of erythropoietin leads to defects in cardiac morphogenesis. Development 126:3597-3605
55. Yu X, Shacka JJ, Eells JB, Suarez-Quian C, Przygodzki RM, Beleslin-Cokic B, Lin CS, Nikodem VM, Hempstead B, Flanders KC, Costantini F, Noguchi CT 2002 Erythropoietin receptor signaling is required for normal brain development. Development 129:505-516
56. Jelkmann W 1992 Erythropoietin: structure, control of production, and function. Physiol Rev 72:449-489
57. Masuda S, Nagao N, Takahata K, Konishi Y, Gallyas F Jr, Tabira T, Sasaki R 1993 Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J Biol Chem 268:11208-11216
58. Lewczuk P, Hasselblatt M, Kamrowski-Kruck H, Heyer A, Unzicker C, Siren AL, Ehrenreich H 2000 Survival of hippocampal neurons in culture upon hypoxia: effect of erythropoietin. NeuroReport 11:3485-3488
59. Siren AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, Keenan S, Gleiter C, Pasquali C, Capobianco A, Mennini T, Heumann R, Cerami A, Ehrenreich H, Ghezzi P 2001 Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A 98:4044-4049
60. Marti HH, Wenger RH, Rivas LA, Straumann U, Digicaylioglu M, Henn V, Yonekawa Y, Bauer C, Gassmann M 1996 Erythropoietin gene expression in human, monkey and human brain. Eur J Neurosci 8:666-676
61. Sadamoto Y, Igase K, Sakanaka M, Sato K, Otsuka H, Sakaki S, Masuda S, Sasaki R1998 Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem Biophys Res Commun 253:26-32
62. Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, Petit E 1999 A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19:643-651
63. Siren AL, Knerlich F, Poser W, Gleiter CH, Bruck W, Ehrenreich H 2001 Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol (Berl) 101:271-276
64. Wen TC, Rogido M, Gressens P, Sola A 2004 A reproducible experimental model of focal cerebral ischemia in the neonatal rat. Brain Res Brain Res Protocol 13:76-83
65. Wen TC, Rogido M, Genetta T, Sola A 2004 Permanent focal cerebral ischemia activates erythropoietin receptor in the neonatal rat brain. Neurosci Lett 355:165-168
66. Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R 1997 Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76:105-116
67. Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M, Sasaki R 1998 in vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A 95:4635-4640
68. Sinor AD, Greenberg DA 2000 Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity. Neurosci Lett 290:213-215
69. Shingo T, Sorokan ST, Shimazaki T, Weiss S 2001 Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci 21:9733-9743
70. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A 2000 Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A 97:10526-10531
71. Wen TC, Sadamoto Y, Tanaka J, Zhu PX, Nakata K, Ma YJ, Hata R, Sakanaka M 2002 Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up-regulating Bcl-xL expression. J Neurosci Res 67:795-803
72. Digicaylioglu M, Kaul M, Fletcher L, Dowen R, Lipton SA 2004 Erythropoietin protects cerebrocortical neurons from HIV-1/gp120-induced damage. Neuroreport 15:761-763
73. Kumral A, Ozer E, Yilmaz O, Akhisaroglu M, Gokmen N, Duman N, Ulukus C, Genc S, Ozkan H 2003 Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats. Biol Neonate 83:224-228
74. Aydin A, Genc K, Akhisaroglu M, Yorukoglu K, Gokmen N, Gonullu E 2003 Erythropoietin exerts neuroprotective effect in neonatal rat model of hypoxic-ischemic brain injury. Brain Dev 25:494-498
75. Matsushita H, Johnston MV, Lange MS, Wilson MA 2003 Protective effect of erythropoietin in neonatal hypoxic ischemia in mice. Neuroreport 14:1757-1761
76. Sun Y, Zhou C, Polk P, Nanda A, Zhang JH 2004 Mechanisms of erythropoietin-induced brain protection in neonatal hypoxia-ischemia rat model. J Cereb Blood Flow Metab 24:259-270
77. Spandou E, Soubasi V, Papoutsopoulou S, Karkavelas G, Simeonidou C, Kaiki-Astara A, Guiba-Tziampiri O 2004 Erythropoietin prevents hypoxia/ischemia-induced DNA fragmentation in an experimental model of perinatal asphyxia. Neurosci Lett 366:24-28
78. Solaroglu I, Solaroglu A, Kaptanoglu E, Dede S, Haberal A, Beskonakli E, Kilinc K 2003 Erythropoietin prevents ischemia-reperfusion from inducing oxidative damage in fetal rat brain. Childs Nerv Syst 19:19-22
79. Wang CH, Liang CL, Huang LT, Liu JK, Hung PH, Sun A, Hung KS ingle intravenous injection of naked plasmid DNA encoding erythropoietin provides neuroprotection in hypoxia-ischemia rats. Biochem Biophys Res Commun 314:1064-1071, 2004S
80. Sola A, Rogido M, Lee B, Genetta T, Wen TC 2005 Erythropoietin after focal cerebral ischemia activates the Jak-Stat signaling pathway and improves brain injury in postnatal day-7 rats. Pediatr Res 57:481-487
81. Kumral A, Uysal N, Tugyan K, Sonmez A, Yilmaz O, Gokmen N, Kiray M, Genc S, Duman N, Koroglu TF, Ozkan H, Genc K 2004 Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats. Behav Brain Res 153:77-86
82. Chang YS, Mu D, Wendland M, Sheldon RA, Vexler ZA, McQuillen PS, Ferriero DM 2005 Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatr Res, in press
83. Digicaylioglu M, Lipton SA 2001 Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412:641-647
84. Kumral A, Baskin H, Gokmen N, Yilmaz O, Genc K, Genc S, Tatli MM, Duman N, Ozer E, Ozkan H 2004 Selective inhibition of nitric oxide in hypoxic-ischemic brain model in newborn rats: is it an explanation for the protective role of erythropoietin? Biol Neonate 85:51-54
85. Ribatti D, Presta M, Vacca A, Ria R, Giuliani R, Dell‘Era P, Nico B, Roncali L, Dammacco F 1999 Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 93:2627-2636
86. Gorio A, Gokmen N, Erbayraktar S, Yilmaz O, Madaschi L, Cichetti C, Di Giulio AM, Vardar E, Cerami A, Brines M 2002 Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc Natl Acad Sci U S A 99:9450-9455
87. Cattaneo E, Conti L, De-Fraja 1999 Signalling through the JAK-STAT pathway in the developing brain. Trends Neurosci 22:365-369
88. Kawakami M, Sekiguchi M, Sato K, Kozaki S, Takahashi M 2000 Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J Biol Chem 276:39469-39475
89. Campana WM, Misasi R, O’Brien JS 1998 Identification of a neurotrophic sequence in erythropoietin. Int J Mol Med 1:235-241
90. Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, Savino C, Bianchi M, Nielsen J, Gerwien J, Kallunki P, Larsen AK, Helboe L, Christensen S, Pedersen LO, Nielsen M, Torup L, Sager T, Sfacteria A, Erbayraktar S, Erbayraktar Z, Gokmen N, Yilmaz O, Cerami-Hand C, Xie QW, Coleman T, Cerami A, Brines M 2004 Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305:239-242
91. Brines M, Grasso G, Fiordaliso F, Sfacteria A, Ghezzi P, Fratelli M, Latini R, Xie QW, Smart J, Su-Rick CJ, Pobre E, Diaz D, Gomez D, Hand C, Coleman T, Cerami A 2004 Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci U S A 101:14907-14912
92. Dzietko M, Felderhoff-Mueser U, Sifringer M, Krutz B, Bittigau P, Thor F, Heumann R, Buhrer C, Ikonomidou C, Hansen HH 2004 Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity. Neurobiol Dis 15:177-187
93. Shannon KM, Keith JF III, Mentzer WC, Ehrenkranz RA, Brown MS, Widness JA, Gleason CA, Bifano EM, Millard DD, Davis CB 1995 Recombinant human erythropoietin stimulate erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 95:1-8
94. Meyer MP, Meyer JH, Commerford A, Hann FM, Sive AA, Moller G, Jacobs P, Malan AF 1994 Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study. Pediatrics 93:918-923
95. Maier RF, Obladen M, Kattner E, Natzschka J, Messer J, Regazzoni BM, Speer CP, Fellman V, Grauel EL, Groneck P, Wagner M, Moriette G, Salle BL, Verellen G, Scigalla P 1998 High- versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group. J Pediatr 132:866-870
96. Shibata J, Hasegawa J, Siemens HJ, Wolber E, Dibbelt L, Li D, Katschinski DM, Fandrey J, Jelkmann W, Gassmann M, Wenger RH, Wagner KF 2003 Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis. Blood 101:4416-4422
97. Casadevall N, Nataf J, Viron B, Kolta A, Kiladjian JJ, Martin-Dupont P, Michaud P, Papo T, Ugo V, Teyssandier I, Varet B, Mayeux P 2002 Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 346:469-475
98. Newton NR, Leonard CH, Piecuch RE, Phibbs RH 1999 Neurodevelopmental outcome of prematurely born children treated with recombinant human erythropoietin in infancy. J Perinatol 19:403-406
99. Juul SE, Stallings SA, Christensen RD 1999 Erythropoietin in the cerebrospinal fluid of neonates who sustained CNS injury. Pediatr Res 46:543-547
100. Juul SE 2002 Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage. Acta Paediatr 438:36-42
101. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F, Bohn M, Poser W, Ruther E, Kochen M, Gefeller O, Gleiter C, Wessel TC, De Ryck M, Itri L, Prange H, Cerami A, Brines M, Siren AL 2002 Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8:495-505
102. Ehrenreich H, Degner D, Meller J, Brines M, Behe M, Hasselblatt M, Woldt H, Falkai P, Knerlich F, Jacob S, von Ahsen N, Maier W, Bruck W, Ruther E, Cerami A, Becker W, Siren AL 2004 Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol Psychiatry 9:42-54
103. Davis LE, Widness JA, Brace RA 2000 Renal and placental secretion of erythropoietin during anemia or hypoxia in the ovine fetus. Am J Obstet Gynecol 189:1764-1770
104. Solaroglu I, Solaroglu A, Kaptanoglu E, Dede S, Haberal A, Beskonakli E, Kilinc K 2003 Erythropoietin prevents ischemia-reperfusion from inducing oxidative damage in fetal rat brain. Childs Nerv Syst 19:19-22
105. Widness JA, Veng-Pedersen P, Peters C, Pereira LM, Schmidt RL, Lowe LS 1996 Erythropoietin pharmacokinetics in premature infants: developmental, nonlinearity, and treatment effects. J Appl Physiol 80:140-148